Skip to main content
PREVIEW · SAMPLE DATA
This is the CCCC dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for CCCC.

CCCC

C4 Therapeutics, Inc.
Biotechnology · Biotechnology
$81.67 sample
+0.72 (+0.89%) 1D
☆ Watch
Market cap
$357.3B
Price as of
2026-10-29
Latest filing
8-K
Alerts
8
Price$81.67 +12.37% 3M daily closessample
85.2872.08
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 20INSInsider sell: Director
  • Oct 13INSInsider sell: 10% owner
  • Oct 06INSInsider sell: General Counsel
  • Oct 01INSInsider sell: Chief Executive Officer
  • Sep 24INSInsider sell: Chief Executive Officer
  • Sep 17INSInsider buy: Chief Executive Officer
  • Sep 09INSInsider sell: Chief Executive Officer
  • Sep 04INSInsider buy: EVP, Operations
Sign up to see the real CCCC record →

Company facts

SEC EDGAR registration
Name
C4 Therapeutics, Inc.
Sector
Biotechnology
Industry
Biotechnology
Smart-money score
-31sample, -100 to +100
Reporting currency
USD

Who is positioning in CCCC

sample
Insiders
15 insider transactions over 90 days, net selling, $699.6M
Congress
1 members traded over 90 days
Institutions · 13F
9 funds hold $3.3B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$21.7B +22.2% y/y
Q4 2024Q3 2026
Inventory$13.1B +13.7% y/y
Q4 2024Q3 2026
Accounts receivable$9.2B +6.2% y/y
Q4 2024Q3 2026
Total debt$25.6B +12.4% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$100.0B -9.8% 3M
Sample peer B
$207.2B +8.3% 3M
Sample peer C
$355.9B +13.3% 3M
Sample peer D
$216.5B -5.8% 3M
Sample peer E
$273.9B +8.5% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not CCCC's real figure. Nothing here is investment advice.